MRK vs TCPC · P/E 33, rev $16.61B vs rev $95.2M
Merck & Company Inc (MRK) versus BlackRock TCP Capital Corp (TCPC) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
BlackRock TCP Capital Corp (TCPC) is a asset management company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported TCPC revenue for 2025-12-31 was $95.2M. Net income was -$88.9M. Revenue was down 16.5% from 2024-12-31 to 2025-12-31. TCPC currently screens at market cap $284.4M.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. TCPC currently screens at market cap $284.4M.
Not investment advice. Open the MRK and TCPC stock pages for the full models.
Not investment advice.